Michael G. Grey, Director at Mirati Therapeutics, Inc. (MRTX), sold 21,711 shares at $241.22 ($5.3M) on 2020-12-14, disclosed to the SEC on 2020-12-16.
Open-market sale of $5.3M MRTX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $241.22 | 379 | $91K | 1.7% |
| 2 | $241.22 | 379 | $91K | 1.7% |
| 3 | $242.29 | 857 | $208K | 3.9% |
| 4 | $242.29 | 857 | $208K | 3.9% |
| 5 | $243.35 | 1,815 | $442K | 8.3% |
| 6 | $243.35 | 1,815 |
| $442K |
| 8.3% |
| 7 | $244.45 | 1,653 | $404K | 7.6% |
| 8 | $244.45 | 1,653 | $404K | 7.6% |
| 9 | $245.11 | 1,284 | $315K | 5.9% |
| 10 | $245.11 | 1,284 | $315K | 5.9% |
| 11 | $246.73 | 1,807 | $446K | 8.4% |
| 12 | $246.73 | 1,807 | $446K | 8.4% |
| 13 | $247.62 | 1,997 | $494K | 9.3% |
| 14 | $247.62 | 1,997 | $494K | 9.3% |
| 15 | $248.55 | 1,019 | $253K | 4.8% |
| 16 | $248.55 | 1,019 | $253K | 4.8% |
| 17 | $249.42 | 89 | $22K | 0.4% |
| Total | $245.43 avg | 21,711 | $5.3M | 100% |
| Filing → |
| MIRM | SELL | 2025-11-25 | $3.5M | — | Filing → |
| MIRM | SELL | 2023-09-14 | $467K | — | Filing → |
| MIRM | SELL | 2023-06-09 | $424K | — | Filing → |